Antiphospholipid syndrome as a neurological disease

Carlos Ewerton Maia Rodrigues, Jozélio Freire Carvalho, Yehuda Shoenfeld*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Neurologic disorders are among the most comum and important clinical manifestations associated with the antiphospholipid syndrome (APS), mainly those that affects the central nervous system (CNS). These include sroke, transient ischemic attack, Sneddon's syndrome, convulsions/epilepsy, dementia, cognitive deficits, headaches/migraine, chorea, multiple sclerosis-like, transverse myelitis, ocular symptoms and Guillain-Barré syndrome. On the other hand, only one study investigated the occurrence of peripheral neuropathy and showed alterations in 35 % of PAPS patients. The proposed mechanisms of nervous system involvement in APS are: thrombosis, and antiphospholipid antibodiesbinding CNS, leading to deregulation of its functions. This article updates the data regarding the clinical aspects related to major neurologic manifestations associated to antiphospholipid syndrome.

Original languageEnglish
Pages (from-to)12-17
Number of pages6
JournalCurrent Rheumatology Reviews
Volume6
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Keywords

  • Antiphospholipid antibodies
  • Antiphospholipid syndrome
  • Hughes' syndrome
  • Neurological manifestations

Fingerprint

Dive into the research topics of 'Antiphospholipid syndrome as a neurological disease'. Together they form a unique fingerprint.

Cite this